Table 3.
Efficacy outcomes of the patients who underwent EVT (alone or combined with IVT) during the two study periods.
| Outcome | 23rd March to 30th June 2020 (n = 57) | 23rd March to 30th June 2019 (n = 44) | P |
|---|---|---|---|
| mRS at 90 days, (median, IQR) | 3; 0–6 | 3; 0–6 | 0.403 |
| Functional independence at 90 days [mRS 0–2, n (%)] | 20 (35.09%) | 15 (34.09%) | 0.367 |
| Death at 90 days | 12 (21.05%) | 15 (34.09%) | 0.283 |
mRS, modified Rankin Scale; IQR, interquartile range.